High-intensity focused ultrasound
Citation, DOI, disclosures and article data
At the time the article was created Stefano Pacifici had no recorded disclosures.View Stefano Pacifici's current disclosures
High-intensity focussed ultrasound (HIFU), sometimes referred to as focused ultrasound surgery (FUS), is a promising non-invasive thermal ablation technique.
Unlike diagnostic ultrasound, HIFU focuses the ultrasound waves precisely upon a target. In a similar way to how light can be focused to a burning point by a magnifying glass, ultrasound passes through the body without any effect but generating lethal heat (>65oC) exactly where they are focused.
Image guidance of HIFU
HIFU can be guided by MRI or ultrasound. MRI has the advantage of improved anatomical resolution and may provide quantification of temperature around the ablation zone. Ultrasound is the cheapest imaging modality available that provides real-time images using the same form of energy used for treatment. Independent of imaging modality, the advantage of this technique is its non-invasive nature and therefore higher patient acceptability and improved cosmetic outcomes.
Already established in the treatment of other pathologies (e.g. uterine fibroids), this technique applied to breast tumors in several trials in progress seems to be promising.
- 1. Orsi F, Arnone P, Chen W, Zhang L. High Intensity Focused Ultrasound Ablation: A New Therapeutic Option for Solid Tumors. J Cancer Res Ther. 2010;6(4):414-20. doi:10.4103/0973-1482.77064 - Pubmed
- 2. Zhang L & Wang Z. High-Intensity Focused Ultrasound Tumor Ablation: Review of Ten Years of Clinical Experience. Front Med China. 2010;4(3):294-302. doi:10.1007/s11684-010-0092-8 - Pubmed
- 3. Kim S, Jung S, Kim H, Hahn S, Park G, Park W. The Potential Role of Dynamic MRI in Assessing the Effectiveness of High-Intensity Focused Ultrasound Ablation of Breast Cancer. Int J Hyperthermia. 2010;26(6):594-603. doi:10.3109/02656736.2010.481275 - Pubmed
- 4. Hung B. The Effect of High Intensity Focused Ultrasound Ablation of Human Breast Cancer. Surgery. 2010;147(3):466-7. doi:10.1016/j.surg.2009.04.018 - Pubmed